Strata Critical Medical Stock Performance

SRTA Stock   4.43  0.12  2.64%   
The entity has a beta of 2.79, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Strata Critical will likely underperform. At this point, Strata Critical Medical has a negative expected return of -0.0353%. Please make sure to validate Strata Critical's value at risk, as well as the relationship between the expected short fall and day median price , to decide if Strata Critical Medical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Strata Critical Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Strata Critical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more

Actual Historical Performance (%)

One Day Return
(2.78)
Five Day Return
(2.15)
Year To Date Return
(7.71)
Ten Year Return
(53.33)
All Time Return
(53.33)
1
Disposition of 11000 shares by Love Reginald of Strata Critical at 4.3122 subject to Rule 16b-3
11/19/2025
2
Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors
12/03/2025
3
Acquisition by Lauck Andrew of 5000 shares of Strata Critical at 4.365 subject to Rule 16b-3
12/05/2025
4
Acquisition by William Heyburn of 17000 shares of Strata Critical at 4.4732 subject to Rule 16b-3
12/09/2025
5
Disposition of 3716 shares by Amir Cohen of Strata Critical at 4.38 subject to Rule 16b-3
12/10/2025
6
Disposition of 276960 shares by Tomkiel Melissa M. of Strata Critical at 0.18 subject to Rule 16b-3
01/02/2026
7
Strata Critical Medical Likely Valuation Re-Rating After Q4 Earnings - Seeking Alpha
01/29/2026
Begin Period Cash Flow29 M
Total Cashflows From Investing Activities-1 M

Strata Critical Relative Risk vs. Return Landscape

If you would invest  489.00  in Strata Critical Medical on November 13, 2025 and sell it today you would lose (34.00) from holding Strata Critical Medical or give up 6.95% of portfolio value over 90 days. Strata Critical Medical is currently does not generate positive expected returns and assumes 4.2054% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Strata, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Strata Critical is expected to under-perform the market. In addition to that, the company is 5.41 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Strata Critical Target Price Odds to finish over Current Price

The tendency of Strata Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.43 90 days 4.43 
about 83.66
Based on a normal probability distribution, the odds of Strata Critical to move above the current price in 90 days from now is about 83.66 (This Strata Critical Medical probability density function shows the probability of Strata Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.79 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Strata Critical will likely underperform. Additionally Strata Critical Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Strata Critical Price Density   
       Price  

Predictive Modules for Strata Critical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Strata Critical Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Strata Critical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.354.568.77
Details
Intrinsic
Valuation
LowRealHigh
0.204.018.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.020.020.02
Details

Strata Critical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Strata Critical is not an exception. The market had few large corrections towards the Strata Critical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Strata Critical Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Strata Critical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.18
β
Beta against Dow Jones2.79
σ
Overall volatility
0.51
Ir
Information ratio -0.0065

Strata Critical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Strata Critical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Strata Critical Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Strata Critical generated a negative expected return over the last 90 days
Strata Critical has high historical volatility and very poor performance
Strata Critical Medical was previously known as Blade Air Mobility and was traded on NASDAQ Exchange under the symbol BLDE.
The company reported the previous year's revenue of 248.69 M. Net Loss for the year was (27.31 M) with profit before overhead, payroll, taxes, and interest of 13.17 M.
Strata Critical generates negative cash flow from operations
Strata Critical has a poor financial position based on the latest SEC disclosures
About 69.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Strata Critical Medical Likely Valuation Re-Rating After Q4 Earnings - Seeking Alpha

Strata Critical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Strata Stock often depends not only on the future outlook of the current and potential Strata Critical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Strata Critical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding77.5 M
Cash And Short Term Investments127.1 M

Strata Critical Fundamentals Growth

Strata Stock prices reflect investors' perceptions of the future prospects and financial health of Strata Critical, and Strata Critical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Strata Stock performance.

About Strata Critical Performance

By analyzing Strata Critical's fundamental ratios, stakeholders can gain valuable insights into Strata Critical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Strata Critical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Strata Critical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 5.74  7.61 
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.13)(0.14)
Return On Assets(0.10)(0.10)
Return On Equity(0.11)(0.12)

Things to note about Strata Critical Medical performance evaluation

Checking the ongoing alerts about Strata Critical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Strata Critical Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Strata Critical generated a negative expected return over the last 90 days
Strata Critical has high historical volatility and very poor performance
Strata Critical Medical was previously known as Blade Air Mobility and was traded on NASDAQ Exchange under the symbol BLDE.
The company reported the previous year's revenue of 248.69 M. Net Loss for the year was (27.31 M) with profit before overhead, payroll, taxes, and interest of 13.17 M.
Strata Critical generates negative cash flow from operations
Strata Critical has a poor financial position based on the latest SEC disclosures
About 69.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Strata Critical Medical Likely Valuation Re-Rating After Q4 Earnings - Seeking Alpha
Evaluating Strata Critical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Strata Critical's stock performance include:
  • Analyzing Strata Critical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Strata Critical's stock is overvalued or undervalued compared to its peers.
  • Examining Strata Critical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Strata Critical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Strata Critical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Strata Critical's stock. These opinions can provide insight into Strata Critical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Strata Critical's stock performance is not an exact science, and many factors can impact Strata Critical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Strata Stock analysis

When running Strata Critical's price analysis, check to measure Strata Critical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strata Critical is operating at the current time. Most of Strata Critical's value examination focuses on studying past and present price action to predict the probability of Strata Critical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strata Critical's price. Additionally, you may evaluate how the addition of Strata Critical to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity